These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35717591)

  • 1. Modeling secondary cancer risk ratios for proton versus carbon ion beam therapy: A comparative study based on the local effect model.
    Hufnagl A; Johansson G; Siegbahn A; Durante M; Friedrich T; Scholz M
    Med Phys; 2022 Aug; 49(8):5589-5603. PubMed ID: 35717591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Relative Biological Effectiveness and Clinical Outcome of Prostate Cancer Therapy Using Particle Irradiation: Analysis of Tumor Control Probability With the Modified Microdosimetric Kinetic Model.
    Besuglow J; Tessonnier T; Mein S; Eichkorn T; Haberer T; Herfarth K; Abdollahi A; Debus J; Mairani A
    Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1545-1556. PubMed ID: 38423224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First application of the BIANCA biophysical model to carbon-ion patient cases.
    Kozłowska WS; Carante MP; Aricò G; Embriaco A; Ferrari A; Magro G; Mairani A; Ramos R; Sala P; Georg D; Ballarini F
    Phys Med Biol; 2022 May; 67(11):. PubMed ID: 35576922
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
    Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
    Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
    Eichkorn T; Karger CP; Brons S; Koerber SA; Mielke T; Haberer T; Debus J; Herfarth K
    Radiother Oncol; 2022 Aug; 173():223-230. PubMed ID: 35714806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton Therapy.
    Eley JG; Friedrich T; Homann KL; Howell RM; Scholz M; Durante M; Newhauser WD
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):279-286. PubMed ID: 27084647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect?
    Gillmann C; Lomax AJ; Weber DC; Jäkel O; Karger CP
    Radiother Oncol; 2018 Jul; 128(1):109-114. PubMed ID: 29459152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of Single Field Multi-Ion Particle Therapy Treatments.
    Kopp B; Mein S; Dokic I; Harrabi S; Böhlen TT; Haberer T; Debus J; Abdollahi A; Mairani A
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):194-205. PubMed ID: 31610250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Monte Carlo-based treatment-planning tool for ion beam therapy.
    Böhlen TT; Bauer J; Dosanjh M; Ferrari A; Haberer T; Parodi K; Patera V; Mairani A
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i77-81. PubMed ID: 23824131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning.
    Elsässer T; Weyrather WK; Friedrich T; Durante M; Iancu G; Krämer M; Kragl G; Brons S; Winter M; Weber KJ; Scholz M
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1177-83. PubMed ID: 20732758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Validation of the BIANCA Biophysical Model: Benchmarking against Rat Spinal Cord RBE Data.
    Carante MP; Aricò G; Ferrari A; Karger CP; Kozlowska W; Mairani A; Sala P; Ballarini F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra.
    Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy.
    Stokkevåg CH; Fukahori M; Nomiya T; Matsufuji N; Engeseth GM; Hysing LB; Ytre-Hauge KS; Rørvik E; Szostak A; Muren LP
    Radiother Oncol; 2016 Aug; 120(2):300-6. PubMed ID: 27424291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
    Mattke M; Ohlinger M; Bougatf N; Harrabi S; Wolf R; Seidensaal K; Welzel T; Röder F; Gerum S; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Uhl M; Debus J
    Strahlenther Onkol; 2023 Feb; 199(2):160-168. PubMed ID: 36149438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive comparison of local effect model IV predictions with the particle irradiation data ensemble.
    Pfuhl T; Friedrich T; Scholz M
    Med Phys; 2022 Jan; 49(1):714-726. PubMed ID: 34766635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUD-based biological optimization for carbon ion therapy.
    Brüningk SC; Kamp F; Wilkens JJ
    Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.